1. Home
  2. ESPR vs RMT Comparison

ESPR vs RMT Comparison

Compare ESPR & RMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • RMT
  • Stock Information
  • Founded
  • ESPR 2008
  • RMT 1993
  • Country
  • ESPR United States
  • RMT United States
  • Employees
  • ESPR N/A
  • RMT N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • RMT Investment Managers
  • Sector
  • ESPR Health Care
  • RMT Finance
  • Exchange
  • ESPR Nasdaq
  • RMT Nasdaq
  • Market Cap
  • ESPR 445.6M
  • RMT 460.2M
  • IPO Year
  • ESPR 2013
  • RMT N/A
  • Fundamental
  • Price
  • ESPR $2.76
  • RMT $10.27
  • Analyst Decision
  • ESPR Buy
  • RMT
  • Analyst Count
  • ESPR 6
  • RMT 0
  • Target Price
  • ESPR $6.50
  • RMT N/A
  • AVG Volume (30 Days)
  • ESPR 6.0M
  • RMT 111.5K
  • Earning Date
  • ESPR 11-06-2025
  • RMT 01-01-0001
  • Dividend Yield
  • ESPR N/A
  • RMT 7.37%
  • EPS Growth
  • ESPR N/A
  • RMT N/A
  • EPS
  • ESPR N/A
  • RMT 1.49
  • Revenue
  • ESPR $268,125,000.00
  • RMT N/A
  • Revenue This Year
  • ESPR $9.87
  • RMT N/A
  • Revenue Next Year
  • ESPR N/A
  • RMT N/A
  • P/E Ratio
  • ESPR N/A
  • RMT $6.18
  • Revenue Growth
  • ESPR N/A
  • RMT N/A
  • 52 Week Low
  • ESPR $0.69
  • RMT $7.67
  • 52 Week High
  • ESPR $3.94
  • RMT $9.51
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 71.69
  • RMT 60.56
  • Support Level
  • ESPR $2.69
  • RMT $10.17
  • Resistance Level
  • ESPR $2.85
  • RMT $10.45
  • Average True Range (ATR)
  • ESPR 0.17
  • RMT 0.15
  • MACD
  • ESPR -0.00
  • RMT -0.02
  • Stochastic Oscillator
  • ESPR 82.72
  • RMT 66.04

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.

Share on Social Networks: